Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma
Clinical trial NCT04552223 · COMPLETED
Trial details
- NCT number
- NCT04552223
- Sponsor
- Jose Lutzky, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-10
- Primary completion
- 2024-01-04
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.